Toll Free: 1-888-928-9744
Published: Oct, 2014 | Pages:
37 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Reliance Life Sciences Pvt. Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Reliance Life Sciences Pvt. Ltd. - Product Pipeline Review - 2014', provides an overview of the Reliance Life Sciences Pvt. Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Reliance Life Sciences Pvt. Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Reliance Life Sciences Pvt. Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Reliance Life Sciences Pvt. Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Reliance Life Sciences Pvt. Ltd.'s pipeline products Reasons to buy - Evaluate Reliance Life Sciences Pvt. Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Reliance Life Sciences Pvt. Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Reliance Life Sciences Pvt. Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Reliance Life Sciences Pvt. Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Reliance Life Sciences Pvt. Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Reliance Life Sciences Pvt. Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Reliance Life Sciences Pvt. Ltd. Snapshot 5 Reliance Life Sciences Pvt. Ltd. Overview 5 Key Information 5 Key Facts 5 Reliance Life Sciences Pvt. Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Reliance Life Sciences Pvt. Ltd. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Reliance Life Sciences Pvt. Ltd. - Pipeline Products Glance 11 Reliance Life Sciences Pvt. Ltd. - Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 Reliance Life Sciences Pvt. Ltd. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Reliance Life Sciences Pvt. Ltd. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Discovery Products/Combination Treatment Modalities 15 Reliance Life Sciences Pvt. Ltd. - Drug Profiles 16 infliximab biosimilar 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 RTPR-013 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 RTPR-026 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 trastuzumab biosimilar 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 ReliDerm-DT 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 ReliDerm-M 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 RHSC-001 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 pegfilgrastim 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 RSCL-0520 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Small Interference RNA for Undisclosed Indications 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Flavanthridine 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Monoclonal Antibodies for Oncology and Inflammation 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Small Molecules for Inflammatory Disorders 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Reliance Life Sciences Pvt. Ltd. - Pipeline Analysis 29 Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Target 29 Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Route of Administration 30 Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Molecule Type 31 Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Mechanism of Action 32 Reliance Life Sciences Pvt. Ltd. - Dormant Projects 33 Reliance Life Sciences Pvt. Ltd. - Locations And Subsidiaries 34 Head Office 34 Other Locations & Subsidiaries 34 Appendix 36 Methodology 36 Coverage 36 Secondary Research 36 Primary Research 36 Expert Panel Validation 36 Contact Us 37 Disclaimer 37
List of Tables Reliance Life Sciences Pvt. Ltd., Key Information 5 Reliance Life Sciences Pvt. Ltd., Key Facts 5 Reliance Life Sciences Pvt. Ltd. - Pipeline by Indication, 2014 8 Reliance Life Sciences Pvt. Ltd. - Pipeline by Stage of Development, 2014 9 Reliance Life Sciences Pvt. Ltd. - Monotherapy Products in Pipeline, 2014 10 Reliance Life Sciences Pvt. Ltd. - Phase III, 2014 11 Reliance Life Sciences Pvt. Ltd. - Phase II, 2014 12 Reliance Life Sciences Pvt. Ltd. - Phase I, 2014 13 Reliance Life Sciences Pvt. Ltd. - Preclinical, 2014 14 Reliance Life Sciences Pvt. Ltd. - Discovery, 2014 15 Reliance Life Sciences Pvt. Ltd. - Pipeline by Target, 2014 29 Reliance Life Sciences Pvt. Ltd. - Pipeline by Route of Administration, 2014 30 Reliance Life Sciences Pvt. Ltd. - Pipeline by Molecule Type, 2014 31 Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Mechanism of Action, 2014 32 Reliance Life Sciences Pvt. Ltd. - Dormant Developmental Projects,2014 33 Reliance Life Sciences Pvt. Ltd., Other Locations 34 Reliance Life Sciences Pvt. Ltd., Subsidiaries 35
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.